Effect of Nutritional Supplement Momordica Charantia in Type 2 Diabetes Mellitus
Phase 4
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/06/068929
- Lead Sponsor
- Kancherla Narasimha Abhinav Kaushal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with type 2 diabetes mellitus
Patients receiving two drugs (Sulfonylureas (Glimepiride) + Metformin) for a minimum period of 12 weeks
Patients with HbA1c 6.5 To 8%
Exclusion Criteria
Patients with type 2 diabetes mellitus receiving insulin
Patients with liver dysfunction
Patients who are on treatment with either steroids or immunosuppressive agents
Pregnancy or Lactation
Patients with renal impairment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method